Industry news

Russian scientists develop revolutionary drugs for cancer, HIV and tuberculosis

Marchmont Innovation News

Russian scientists are developing three types of next gen vaccines that might evolve into the revolutionary drugs for cancer, HIV and tuberculosis, Informing.ru  reported , citing Vladimir Uiba, the director of Russia’s Federal Agency for Medicine and Biology. 
 

What VC Firms Need to Know About Branding

Bloomberg

July 23 (Bloomberg) -- National Venture Capital Association's Emily Mendell discusses venture capital branding with Deirdre Bolton on Bloomberg Television's "Money Moves". (Source: Bloomberg)

How to invest in Russian technoparks

Daniil Zhelobanov, Russia Beyonds the Headlines

Technoparks can be a boon for both foreign investors willing to set up their business in Russia.

Venture capital warms to European biotechs

Caroline Copley, Reuters

While a wave of stock market enthusiasm in the United States for biotech company flotations has yet to cross the Atlantic, venture capital appetite for promising European companies is returning.

Amount of private investments in Skolkovo can reach 367B RUB

Venture News

According to the Chief of the Fund Skolkovo Viktor Vekselberg, till the year 2020 the amount of private investments in the project of innovation center can reach 367B RUB, and after the year 2025 the budget funds for the project will not be required.
 

Russian government to regulate prices for essential drugs

The Pharma Letter

The Russian government is considering tightening its pricing policy in the domestic market for essential drugs, with the aim of preventing unreasonable price rises for them in the future. According to the Russian Ministry of Health, it is planned that ceiling prices for foreign essential drugs sold in Russia will not exceed the average European prices for the same types of drugs.

31 July 2013

Kaluga eyes new site to produce FDA-approved innovation drugs

Marchmont Innovation News

The Kaluga region in Central Russia, the city of Kaluga and NovaMedica, a young Russian pharma, have agreed to build a new pharmaceutical factory in the area, Rusnano  reports . 

BioPharmCluster “Nothern” and Technopolis Moscow have executed a cooperation

Venture News

BioPharmCluster “Nothern”, created on the basis of Moscow Institute of Physics and Technology, and Technopolis Moscow executed a memorandum on cooperation in the sphere of innovation technologies development in hi-tech economy branches.

Pharma industry on cusp of golden era, PwC says

Kate Ryzhkova, Oksana Teplinskaya, The Voice of Russia

Russia’s pharma-industry is on the cusp of a golden era, states a recent report from PwC on the sector called “Pharma 2020: From Vision to Decision”. Major scientific and technological advances, alongside socio-demographic changes and increasing demand for medicines, will revive pharma’s fortunes post 2020, PwC’s experts claim.

Skolkovo and South California University agreed on cooperation

Venture News

Technopark Skolkovo visited deputy Dean of natural sciences Faculty of the South California University, professor of chemistry Charles McCann.